Peroxin 16 inhibitors are a class of chemical compounds that specifically target the Peroxin 16 (Pex16) protein, which plays a vital role in the biogenesis and maintenance of peroxisomes. Peroxisomes are essential cellular organelles involved in lipid metabolism, detoxification, and the breakdown of fatty acids. Pex16 is integral to the formation and maintenance of peroxisomes by helping in the proper targeting and assembly of peroxisomal membrane proteins (PMPs). By regulating the import of PMPs into peroxisomal membranes, Pex16 ensures the correct assembly of functional peroxisomes, which is essential for various metabolic pathways. Inhibitors of Pex16 disrupt this process by interfering with its ability to facilitate PMP import, thereby impairing peroxisome assembly and function.
The development of Peroxin 16 inhibitors involves identifying small molecules that can selectively bind to Pex16, particularly at sites responsible for its interaction with PMPs or other components involved in peroxisomal biogenesis. These inhibitors act by blocking the functional domains of Pex16, preventing it from carrying out its normal role in the organelle's formation and maintenance. This disruption in peroxisomal function can lead to alterations in cellular lipid metabolism and the processing of fatty acids, as the proper assembly of peroxisomes is critical for these metabolic processes. Peroxin 16 inhibitors serve as valuable tools for investigating the molecular mechanisms that underlie peroxisome biogenesis and provide insights into the broader role of peroxisomes in cellular metabolism and homeostasis. By using these inhibitors, researchers can explore how Pex16 contributes to peroxisomal dynamics and the effects of impaired peroxisome function on cellular metabolism.
SEE ALSO...
Items 11 to 19 of 19 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, affecting protein folding and transport, which might influence PEX16 function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
By inhibiting GSK-3β, it might affect Wnt/β-catenin and other signaling pathways that could indirectly regulate PEX16. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that affects cellular ion balance and might interfere with proper protein trafficking or localization, potentially impacting PEX16. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibitor of dynamin, which might influence vesicular trafficking pathways affecting PEX16's functionality. | ||||||
2-Bromohexadecanoic acid | 18263-25-7 | sc-251714 sc-251714A | 10 g 50 g | $53.00 $201.00 | 4 | |
An inhibitor of protein palmitoylation, which could affect the localization or interaction of proteins within membranes and might impact PEX16. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
An inhibitor of fatty acid synthase; by affecting lipid biosynthesis, it could impact peroxisomal membranes and indirectly PEX16 functionality. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubules; might impact the trafficking or localization of peroxisomes and indirectly influence PEX16. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
An inhibitor of Ras farnesyltransferase, affecting the Ras signaling pathway, which might have downstream effects impacting PEX16. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Binds sterols and disrupts lipid rafts; could affect the membrane environment and indirectly the functionality of PEX16. | ||||||